Diagnosis of latent tuberculosis infection in 2007: the tuberculin skin test or specific interferon-γ?;Méthodes diagnostiques de l'infection tuberculeuse en 2007 : intradermoréaction à la tuberculine ou interféron-γ ?

Revue de Medecine Interne

Volumn 28, Issue 3, 2007, Pages 147-150

  Heym, B ^a   Chinet, T ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Diagnostic test; ESAT 6 and CFP 10 antigens; Interferon ; Latent tuberculosis infection; Specific induction; Tuberculin skin test

Indexed keywords

GAMMA INTERFERON;

ARTICLE; HUMAN; INTERFERON PRODUCTION; LATENT PERIOD; TUBERCULIN TEST; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HUMANS; INTERFERON TYPE II; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33947134431     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.12.006     Document Type: Article

References (46)

1. Brosch R., Gordon S.V., Marmiesse M., Brodin P., Buchrieser C., Eiglmeier K., et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 12 (2002) 3684-3689
2. Anonymous. Tuberculosis, fact sheet. 2006. http://www.who.int/mediacentre/factsheets/fs104/en/index.html.
3. Anonymous. Global tuberculosis report. 2006. http://www.who.int/tb/publications/global_report/en/.
4. Horsburgh Jr. C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med. 350 (2004) 2060-2067
5. Ferebee S.H. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv. Tuberc. Res. 17 (1969) 29-106
6. Sterling T.R., Bethel J., Goldberg S., Weinfurter P., Yun L., and Horsburgh C.R. The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am. J. Respir. Crit. Care Med. 173 (2006) 927-931
7. Seibert F.B., Figueroa E.S., and Dufour E.H. Isolation, identification, and classification of proteins of tuberculin and the tubercle bacillus. Am. Rev. Tuberc. 71 (1955) 704-721
8. Huebner R.E., Schein M.F., and Bass Jr. J.B. The Tuberculin Skin Test. Clin. Infect. Dis. 17 (1993) 968-975
9. Arend S.M., Van Meijgaarden K.E., de Boer K., de Palou E.C., Van Soolingen D., Ottenhoff T.H., et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or Mycobacterium kansasii. J. Infect. Dis. 186 (2002) 1797-1807
10. Wang L., Turner M.O., Elwood R.K., Schulzer M., and Fitzgerald J.M. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57 (2002) 804-809
11. Cobelens F.G., Egwaga S.M., Van Ginkel T., Muwinge H., Matee M.I., and Borgdorff M.W. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cut-off values. Clin. Infect. Dis. 43 (2006) 634-639
12. Lendrum J.D. Technique of jelly (tuberculin) skin-testing; comparison between various techniques and the Mantoux test. BMJ 2 (1951) 148-151
13. Jordan T.J., Sunderam G., Thomas L., and Reichman L.B. Tuberculin reaction size measurement by the pen method compared to traditional palpation. Chest 92 (1987) 234-236
14. Bouros D., Maltezakis G., Tzanakis N., Tzortzaki E., and Siafakas N. The role of inexperience in measuring tuberculin skin reaction (Mantoux test) by the pen or palpation technique. Respir. Med. 86 (1992) 219-223
15. Johnson P.D., Stuart R.L., Grayson M.L., Olden D., Clancy A., Ravn P., et al. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin. Diagn. Lab. Immunol. 6 (1999) 934-937
16. Bellamy R. Interferon-gamma and host susceptibility to tuberculosis. Am. J. Respir. Crit. Care Med. 167 (2003) 946-947
17. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170 (2004) 59-64
18. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
19. Richeldi L., Ewer K., Losi M., Roversi P., Fabbri L.M., and Lalvani A. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 61 (2006) 180
20. Harboe M., Malin A.S., Dockrell H.S., Wiker H.G., Ulvund G., Holm A., et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect. Immun. 66 (1998) 717-723
21. Mustafa A.S., Oftung F., Amoudy H.A., Madi N.M., Abal A.T., Shaban F., et al. Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. Clin. Infect. Dis. 30 Suppl 3 (2000) S201-S205
22. Brock I., Munk M.E., Kok-Jensen A., and Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis. 5 (2001) 462-467
23. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular Analysis of genetic differences between Mycobacterium bovis BCG and virulent Mycobacterium bovis. J. Bacteriol. 178 (1996) 1274-1282
24. Gordon S.V., Brosch R., Billault A., Garnier T., Eiglmeier K., and Cole S.T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32 (1999) 643-655
25. Ramakrishnan L., Federspiel N., and Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins proteins from the glycine-rich PE-PGRS family. Science 288 (2000) 1436-1439
26. Gioia C., Agrati C., Goletti D., Vincenti D., Carrara S., Amicosante M., et al. Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16 (2003) 247-252
27. Lazarevic V., Nolt D., and Flynn J.L. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175 (2005) 1107-1117
28. Anonymous. QuantiFERON-TB Gold. 2006. http://www.cellestis.com/.
29. Anonymous. T-SPOT.TB. 2006. http://www.oxfordimmunotec.com/.
30. Kang Y.A., Lee H.W., Yoon H.I., Cho B., Han S.K., Shim Y.S., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293 (2005) 2756-2761
31. Lee J.Y., Choi H.J., Park I.N., Hong S.B., Oh Y.M., Lim C.M., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J. 28 (2006) 24-30
32. Taggart E.W., Hill H.R., Ruegner R.G., and Litwin C.M. Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test. Am. J. Clin. Pathol. 125 (2006) 467-473
33. Streeton J.A., Desem N., and Jones S.L. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int. J. Tuberc. Lung Dis. 2 (1998) 443-450
34. Lalvani A., Nagvenkar P., Udwadia Z., Pathan A.A., Wilkinson K.A., Shastri J.S., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183 (2001) 469-477
35. Mazurek G.H., LoBue P.A., Daley C.L., Bernardo J., Lardizabal A.A., Bishai W.R., et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286 (2001) 1740-1747
36. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167 (2001) 5217-5225
37. Stuart R.L., Bennett N.J., Forbes A.B., and Grayson M.L. Assessing the risk of tuberculosis infection among healthcare workers: the Melbourne Mantoux Study. Melbourne Mantoux Study Group. Med. J. Aust. 174 (2001) 569-573
38. Ravn P., Munk M.E., Andersen A.B., Lundgren B., Nielsen L.N., Lillebaek T., et al. Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand. J. Infect. Dis. 36 (2004) 499-501
39. Lalvani A., Richeldi L., and Kunst H. Interferon gamma assays for tuberculosis. Lancet Infect. Dis. 5 (2005) 322-324
40. Tsiouris S.J., Coetzee D., Toro P.L., Austin J., Stein Z., and El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J. Clin. Microbiol. 44 (2006) 2844-2850
41. Lalvani A., Pathan A.A., McShane H., Wilkinson R.J., Latif M., Conlon C.P., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163 (2001) 824-828
42. Davies P.D., and Drobniewski F. The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur. Respir. J. 28 (2006) 1-3
43. Diel R., and Nienhaus A. Lange CSchaberg T. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur. Respir. J. 28 (2006) 35-44
44. Ewer K., Cockle P., Gordon S., Mansoor H., Govaerts M., Walravens K., et al. Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex. Clin Vaccine Immunol. 13 (2006) 90-97
45. Mazurek G.H., and Villarino M.E. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 52 RR-2 (2003) 15-18
46. Mazurek G.H., Jereb J., Lobue P., Iademarco M.F., Metchock B., and Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54 RR-15 (2005) 49-55